Prometheus Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress - On track for topline ARTEMIS-UC Phase 2 and full APOLLO-CD Phase 2a results concurrently in 4Q 2022 - - Initiation of Phase 1 trial of second precision program PRA052 - - Strong cash position...